IP Library › Granted Patent US 11,382,328
Granted Patent B2
US 11,382,328 · App. 16/829,329 · Granted Jul 12, 2022

Rapid drug discovery methods for pathogen inactivation

Inventor: Otakuye Conroy-Ben (Tempe, AZ)
Assignee: Arizona Board of Regents on behalf of Arizona State University
A01N33/20A01N35/02A01N57/20A01N57/34A01N59/16C12N1/18C12Q1/20A01N2300/00C12N1/20C12Q1/00C12Q1/025
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,382,328
App. No.
16/829,329
Granted
Jul 12, 2022
Kind
B2
Abstract

Provided herein are rapid, large-scale screening methods for identifying metal-biocide combinations that are synergistically effective to kill or inhibit the growth of microorganisms. Also provided herein are novel, synergistically antimicrobial metal-biocide combinations and uses of such compositions to curb or slow microbial growth.

Claims (9)

1. A method of screening for synergistically effective metal-biocide combinations, the method comprising:

contacting a microorganism to a test biocide, which is a drug compound or isotope which is not a metal ion, deposited on a solid surface, wherein the microorganism is in a culture medium comprising a soluble Group IB metal;

culturing the contacted microorganism in the culture medium;

screening for a synergistically effective combination of the test biocide and the metal, wherein screening comprises measuring relative growth and determining for the metal-biocide combination a coefficient of drug interaction (CDI) of (A+B)/A×B, wherein A is growth in the presence of the culture medium comprising the soluble Group IB metal but lacking the test biocide normalized to growth in LB medium, B is growth in a same culture medium comprising the test biocide but lacking the Group IB metal normalized to growth in LB medium, and A×B is growth in the culture medium comprising the soluble Group IB metal and the test biocide normalized to growth in LB medium, wherein a combination is synergistically effective against the microorganisms if CDI<0.5; and

repeating the aforementioned steps with additional test biocides.

2. The method of claim 1 , wherein the microorganism is a bacterium.

3. The method of claim 1 , wherein the contacted microorganism is cultured in the culture medium for about 12 to about 24 hours.

4. The method of claim 3 , wherein the contacted microorganism is cultured in the culture medium for about 16 hours.

5. The method of claim 1 , wherein the test biocides each comprise a radioactive isotope, nanomaterial, or plasmid curing agent.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 22, 2020
From: CONROY-BEN, OTAKUYE
To: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Reel/Frame 052470/0802 →
Continuity (2)
Provisional Application 62823126 · Mar 25, 2019
Related Publication 20200305423A1 · Oct 1, 2020